The way a device is developed and designed in the U.S., isn't necessarily the same way a device should be developed in a developing country. It sounds like a no-brainer, but many med-tech companies seeking to expand into developing nations don't consider this and lose time bringing their medical devices to market, according to Product Development Technologies (PDT; Lake Zurich, Illinois), a full service product development firm. (Medical Device Daily)

Despite sweeping healthcare reform legislation, it seems that there is a decline in the confidence that patients have in their ability to access and pay for healthcare, according to a consumer sentiment index from Thomson Reuters (New York). (Medical Device Daily)

Spartan Bioscience (Ottawa), a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, reported the availability of the Spartan RX, the first complete sample-to-result, point-of-care DNA testing system for personalized medicine. (Medical Device Daily)